MedPath

Comparison between the Efficiency of Cinnarizine and Topiramate in the treatment of Vestibular Migraine

Phase 2
Conditions
Ear, Nose and Throat
Registration Number
PACTR201909600414183
Lead Sponsor
faculty of medicine menoufya university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
72
Inclusion Criteria

A. At least five episodes with vestibular symptoms of moderate or severe intensity, each lasting 5 min to 72 h
B. Current or previous history of migraine with or without aura according to the International Classification of Headache Disorders (ICHD)
C. One or more migraine features with at least 50% of the vestibular episodes:
• Headache with at least two of the following characteristics: one-sided location, pulsating quality, moderate or severe pain intensity, or aggravation by routine physical activity
• Photophobia and phonophobia
• Visual aura
D. Not better accounted for by another vestibular or ICHD diagnosis.

Exclusion Criteria

age more than 60 years
age less than 18 years

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the change in monthly frequency of vertigo attacks and migraine attacks during the study , duration of attacks
Secondary Outcome Measures
NameTimeMethod
The cost of the therapy and incidence of side effects
© Copyright 2025. All Rights Reserved by MedPath